Lv21
130 积分 2024-03-23 加入
Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non‐Small Cell Lung Cancer
56分钟前
待确认
FIH dose selection beyond MABEL: Optimizing phase 1 clinical trial starting dose whilst protecting patient safety
19天前
已完结
Beyond MABEL: An Integrative Approach to First in Human Dose Selection of Immunomodulators by the Health and Environmental Sciences Institute (HESI) Immuno‐Safety Technical Committee (ITC)
19天前
已完结
Pharmacokinetic models for first-in-human dose selection of immune-activating products in oncology
19天前
已完结
创新药物剂量探索优化中的临床药理学考量
3个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
4个月前
已完结
Determination of IL-23 Pharmacokinetics by Highly Sensitive Accelerator Mass Spectrometry and Subsequent Modeling to Project IL-23 Suppression in Psoriasis Patients Treated with Anti-IL-23 Antibodies
4个月前
已完结
Characterization of Ebastine, Hydroxyebastine, and Carebastine Metabolism by Human Liver Microsomes and Expressed Cytochrome P450 Enzymes: Major Roles for CYP2J2 and CYP3A
7个月前
已完结
Cyclosporin Clinical Pharmacokinetics
8个月前
已完结
Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects
8个月前
已关闭
皖公网安备34019202002308
